Navigation Links
ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City
Date:2/3/2009

SANFORD, Fla., Feb. 3 /PRNewswire/ -- .decimal, Inc. announced today that it has signed an agreement with ProCure Treatment Centers, Inc. to supply patient-specific devices for its proton therapy facility in Oklahoma City, Oklahoma.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

".decimal is excited to have a formal agreement signed with ProCure to be their preferred outsource provider of custom, patient-specific devices utilizing our patented, internet-based manufacturing solution," says Richard Sweat, CEO and President of .decimal.

This agreement calls for proton range compensators and apertures to be manufactured in Sanford, Florida and shipped to the facility in Oklahoma within 24-72 hours. Mark Mills, Senior Vice President of Sales and Marketing for .decimal says, "Signing with ProCure just further strengthens the commitment we have made to the proton therapy industry and specifically to their state-of-the-art facility in Oklahoma City."

.decimal, Inc. has been supplying patient-specific medical devices, as well as other custom machining projects for the University of Florida Proton Therapy Institute since June of 2007. This partnership continues to demonstrate why .decimal, Inc. is the industry leader in partnering with proton therapy facilities worldwide.

"We are proud to partner with ProCure as they roll out proton therapy around the world," says Sweat.

As well as working with proton facilities, .decimal, Inc. supplies close to 200 radiation oncology facilities nationwide with patient-specific devices used in Compensator-Based Intensity Modulated Radiation Therapy (IMRT), including 21st Century Oncology sites and H. Lee Moffitt Cancer and Research Center.

With the addition of the facility in Oklahoma, .decimal will continue to develop new and innovative technologies which will increase patient throughput while providing high quality devices to the patients in Oklahoma City.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced Compensator-Based IMRT delivery, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
3. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
4. ProCure Selects IMPAC as Provider of Oncology Information Systems
5. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
6. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
7. Signalife Continues to Procure Purchase Orders, Revenues
8. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
9. Traditional Risk Factors Often Miss Heart Disease Warning Signs
10. Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries
11. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology:
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOGĀ“s multi-biometrics system.   Continue ... ...
(Date:3/16/2017)... HANOVER, Germany , March 16, 2017 CeBIT 2017 - Against ... Continue Reading ... Used combined in one project, multi-biometric solutions ... ... Identification Systems) ...
Breaking Biology News(10 mins):